NICE has received three appeals against the Final Appraisal Determination on the above technology from the following organisations:

  • Pfizer Limited
  • Leukaemia CARE
  • Jointly appealing: Royal College of Pathologists, Royal College of Physicians and the Association of Cancer Physicians

The appeal panel will convene on Friday 3 November 2017 at NICE, Level 1a, City Tower, Piccadilly Plaza, Manchester M1 4BT to hear oral representations from the appellant.

This page was last updated: